Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3018]

HCC: Improvement in RFS for atezolizumab plus bevacizumab vs active...

Prof Masatoshi Kudo - Kindai University, Higashiōsaka, Japan

HCC: Improvement in RFS for atezolizumab plus bevacizumab vs active surveillance without compromising QoL ( Prof Masatoshi Kudo - Kindai University, Higashiōsaka, Japan )

Adding ribociclib to endocrine therapy shows an improvement in invasive disease...

Prof Dennis Slamon - UCLA, Los Angeles, USA

Adding ribociclib to endocrine therapy shows an improvement in invasive disease-free survival in HR+/HER2 BC patients ( Prof Dennis Slamon - UCLA, Los Angeles, USA )

Nine-weeks trastuzumab still effective compared with one year trastuzumab for...

Prof Pierfranco Conte - Istituto Oncologico Veneto, Padova, Italy

Nine-weeks trastuzumab still effective compared with one year trastuzumab for early-stage HER2 positive breast cancer ( Prof Pierfranco Conte - Istituto Oncologico Veneto, Padova, Italy )

ATTRACTION-5: Nivolumab plus chemotherapy as postoperative adjuvant treatment...

Dr Masanori Terashima - Shizuoka Cancer Center, Nagaizumi, Japan

ATTRACTION-5: Nivolumab plus chemotherapy as postoperative adjuvant treatment for pStage III G/GEJ cancer ( Dr Masanori Terashima - Shizuoka Cancer Center, Nagaizumi, Japan )

NSIA and Nigeria to improve treatment for Nigerians through the building of new...

Aminu Umar-Sadiq - MD & CEO, Nigeria Sovereign Investment Authority (NSIA)

NSIA and Nigeria to improve treatment for Nigerians through the building of new cancer centres ( Aminu Umar-Sadiq - MD & CEO, Nigeria Sovereign Investment Authority (NSIA) )

NSIA and BVGH aim to improve patient outcomes and access to quality cancer care

Dr Tolulope Adewole - Program Lead, MedServe, Nigeria Sovereign Investment...

NSIA and BVGH aim to improve patient outcomes and access to quality cancer care ( Dr Tolulope Adewole - Program Lead, MedServe, Nigeria Sovereign Investment Authority (NSIA) )

Oncologic safety of breast conservation following NACT in women with locally...

Dr Sanjit Agrawal - Tata Medical Center, Kolkata, India

Oncologic safety of breast conservation following NACT in women with locally advanced breast cancer ( Dr Sanjit Agrawal - Tata Medical Center, Kolkata, India )

Maximising diagnosis of colon cancer with target screening

Dr Rimini Breakstone - Lifespan Cancer Institute, Rhode Island, USA

Maximising diagnosis of colon cancer with target screening ( Dr Rimini Breakstone - Lifespan Cancer Institute, Rhode Island, USA )

Optimising colon cancer care in Nigeria

Dr Rimini Breakstone - Lifespan Cancer Institute, Rhode Island, USA

Optimising colon cancer care in Nigeria ( Dr Rimini Breakstone - Lifespan Cancer Institute, Rhode Island, USA )

Current MM diagnosis and treatment strategies

Dr Patricio Duarte - Instituto Universitario CEMIC, Buenos Aires, Argentina

Current MM diagnosis and treatment strategies ( Dr Patricio Duarte - Instituto Universitario CEMIC, Buenos Aires, Argentina )

Low-cost detection and treatment strategies for breast cancer patients in LMICs

Dr Anupama Mane - Ruby Hall Clinic, Pune, India

Low-cost detection and treatment strategies for breast cancer patients in LMICs ( Dr Anupama Mane - Ruby Hall Clinic, Pune, India )

Choosing wisely in breast cancer

Dr Anupama Mane - Ruby Hall Clinic, Pune, India

Choosing wisely in breast cancer ( Dr Anupama Mane - Ruby Hall Clinic, Pune, India )

More from ecancer